Alicia Calderone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alicia Calderone has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Dylan Hansen
St. Vincent's Hospital Melbourne Melbourne Victoria Australia
3 shared publications- Mandana Nikpour
University of Sydney Musculoskeletal Research Flagship Centre and School of Public Health, Camperdown, Sydney, Australia
3 shared publications Alan Silman
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, UK
2 shared publicationsDeborah Yates
Asbestos & Dust Diseases Research Institute, Concord, Australia
2 shared publicationsJoanne Sahhar
Monash Health and Monash University Melbourne Victoria Australia
2 shared publicationsKathleen Morrisroe
Department of Medicine, The University of Melbourne at St Vincent’s Hospital (Melbourne), Fitzroy, Victoria, Australia
2 shared publications
Latest Publications
- Open Access
- 17 November 2025
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 22 (1) , 71
Author Correction: Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases
- 17 November 2025
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 22 (1) , 71
Open AccessAuthor Correction: Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases
- 21 April 2025
- Published by Wiley in Arthritis Care & Research
- Vol. 77 (9) , 1166
Reply
- 5 February 2025
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 21 (3) , 137-156
Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases
Although the association between certain occupational exposures and the development of autoimmune rheumatic disease was first described over a century ago, this association has only become more widely recognized in the past 10 years because of the use of high-silica-content engineered stone in construction and home renovation. There is now a substantial and growing body of evidence that occupational dust and chemical exposure, be it through mining, stonemasonry, building or other trades, increases the risk of various systemic autoimmune rheumatic diseases (SARDs) including rheumatoid arthritis and systemic sclerosis. Although the pathogenic mechanisms of silica-induced autoimmunity are not fully elucidated, it is thought that alveolar macrophage ingestion of silica and the ensuing phagosomal damage is an initiating event that ultimately leads to production of autoantibodies and immune-mediated tissue injury. The purportedly causal association between occupational exposure to chemicals, such as organic solvents, and an increased risk of SARDs is less frequently recognized compared with silica dust, and its immunopathogenesis is less well understood. An appreciation of the importance of occupational dust and chemical exposures in the development of SARDs has implications for workplace health and safety regulations and offers a unique opportunity to better understand autoimmune disease pathogenesis and implement preventative strategies.
- 5 February 2025
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 21 (3) , 137-156
Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases
Although the association between certain occupational exposures and the development of autoimmune rheumatic disease was first described over a century ago, this association has only become more widely recognized in the past 10 years because of the use of high-silica-content engineered stone in construction and home renovation. There is now a substantial and growing body of evidence that occupational dust and chemical exposure, be it through mining, stonemasonry, building or other trades, increases the risk of various systemic autoimmune rheumatic diseases (SARDs) including rheumatoid arthritis and systemic sclerosis. Although the pathogenic mechanisms of silica-induced autoimmunity are not fully elucidated, it is thought that alveolar macrophage ingestion of silica and the ensuing phagosomal damage is an initiating event that ultimately leads to production of autoantibodies and immune-mediated tissue injury. The purportedly causal association between occupational exposure to chemicals, such as organic solvents, and an increased risk of SARDs is less frequently recognized compared with silica dust, and its immunopathogenesis is less well understood. An appreciation of the importance of occupational dust and chemical exposures in the development of SARDs has implications for workplace health and safety regulations and offers a unique opportunity to better understand autoimmune disease pathogenesis and implement preventative strategies.
- 10 November 2024
- Published by Wiley in Arthritis Care & Research
- Vol. 77 (1) , 61-68
Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis Cohort
Objective: The aim of this study was to determine the impact of season, temperature and humidity on the severity of Raynaud phenomenon (RP) in systemic sclerosis.Methods: Data from the Australian Scleroderma Cohort Study were used to assess associations of patient‐reported worsened RP in the month preceding each study visit. Mean monthly weather data were obtained from the closest weather station to the patient's address. We evaluated the relationship between worsened RP and health‐related quality of life (HRQoL) measured using the Short Form 36 instrument.Results: Among 1,972 patients with systemic sclerosis, RP was a near‐universal finding, and worsened RP in the preceding month was reported in 26.7% of 9,175 visits. “Worsened RP” showed significant environmental variability. On multivariable analysis, worsened RP was associated with low mean maximum temperatures (odds ratio [OR] 0.91, 95% confidence interval [95% CI] 0.90–0.92, P < 0.001), high relative humidity (OR 1.05, 95% CI 1.04–1.05, P < 0.001) and lower mean daily evaporation (OR 0.77, 95% CI 0.73–0.81, P < 0.001). Worsened RP was strongly associated with telangiectasia, calcinosis, and digital ulceration, as well as demonstrating an association with anticentromere antibody and gastroesophageal reflux disease and a negative correlation with diffuse disease. Worsened RP was also strongly associated with worse HRQoL.Conclusion: Lower environmental temperature and higher relative humidity had significant associations with worsened RP in this systemic sclerosis cohort, suggesting an important role for dry warmth in managing this condition.
- 10 November 2024
- Published by Wiley in Arthritis Care & Research
- Vol. 77 (1) , 61-68
Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis Cohort
Objective: The aim of this study was to determine the impact of season, temperature and humidity on the severity of Raynaud phenomenon (RP) in systemic sclerosis.Methods: Data from the Australian Scleroderma Cohort Study were used to assess associations of patient‐reported worsened RP in the month preceding each study visit. Mean monthly weather data were obtained from the closest weather station to the patient's address. We evaluated the relationship between worsened RP and health‐related quality of life (HRQoL) measured using the Short Form 36 instrument.Results: Among 1,972 patients with systemic sclerosis, RP was a near‐universal finding, and worsened RP in the preceding month was reported in 26.7% of 9,175 visits. “Worsened RP” showed significant environmental variability. On multivariable analysis, worsened RP was associated with low mean maximum temperatures (odds ratio [OR] 0.91, 95% confidence interval [95% CI] 0.90–0.92, P < 0.001), high relative humidity (OR 1.05, 95% CI 1.04–1.05, P < 0.001) and lower mean daily evaporation (OR 0.77, 95% CI 0.73–0.81, P < 0.001). Worsened RP was strongly associated with telangiectasia, calcinosis, and digital ulceration, as well as demonstrating an association with anticentromere antibody and gastroesophageal reflux disease and a negative correlation with diffuse disease. Worsened RP was also strongly associated with worse HRQoL.Conclusion: Lower environmental temperature and higher relative humidity had significant associations with worsened RP in this systemic sclerosis cohort, suggesting an important role for dry warmth in managing this condition.
- Open Access
- 14 December 2023
- Published by Wiley in Arthritis Care & Research
- Vol. 76 (1) , 81-87
Impact of the COVID‐19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis
Objective: Regular clinical assessment for complications of systemic sclerosis (SSc) such as pulmonary arterial hypertension (PAH) is essential for early institution of therapy and improved outcomes. The objective of this study was to determine the impact of COVID‐19 pandemic‐related restrictions on health care access of patients with SSc, including screening for PAH.Methods: South Australian and Victorian patients enrolled in the Australian Scleroderma Cohort Study were surveyed about their perceptions of the impact of the pandemic on mental well‐being, access to medications, investigations, and management of SSc. Frequency of annual rheumatology assessments, pulmonary function tests (PFT), and transthoracic echocardiography (TTE) to screen for PAH were compared with rates from before the pandemic.Results: A total of 312 of 810 patients with SSc responded (38.5% response); 273 were female (87.5%), the median age was 64.7 years, 77.2% had limited disease, the median illness duration was 15.6 years, 15.7% were immunosuppressed, 32.1% had interstitial lung disease, and 6.4% had PAH. A total of 65.7% of consultations were by telehealth, of which 81.2% were by telephone. Compared with respondents in South Australia (n = 109), Victorian respondents (n = 203) experiencing prolonged lockdown, reported reduced access to their rheumatologist (49.3% vs 27.9%; P = 0.004), greater use of consultation by video (17.3% vs 2.1%; P = 0.008), greater health care disruption (49.0% vs 23.2%; P < 0.001), and worse mental health (P = 0.002). Respondents reported reduced access to PFT and TTE (31.7% and 22.5%, respectively). Annual visits, PFT, TTE, and new diagnoses of PAH were reduced in 2020 to 2022 compared with 2011 to 2019.Conclusion: The COVID‐19 pandemic–related disruption to health care for patients with SSc was associated with worse mental health and reduced screening and diagnosis of PAH, which may impact long‐term outcomes.
- 14 December 2023
- Published by Wiley in Arthritis Care & Research
- Vol. 76 (1) , 81-87
Open AccessImpact of the COVID‐19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis
Objective: Regular clinical assessment for complications of systemic sclerosis (SSc) such as pulmonary arterial hypertension (PAH) is essential for early institution of therapy and improved outcomes. The objective of this study was to determine the impact of COVID‐19 pandemic‐related restrictions on health care access of patients with SSc, including screening for PAH.Methods: South Australian and Victorian patients enrolled in the Australian Scleroderma Cohort Study were surveyed about their perceptions of the impact of the pandemic on mental well‐being, access to medications, investigations, and management of SSc. Frequency of annual rheumatology assessments, pulmonary function tests (PFT), and transthoracic echocardiography (TTE) to screen for PAH were compared with rates from before the pandemic.Results: A total of 312 of 810 patients with SSc responded (38.5% response); 273 were female (87.5%), the median age was 64.7 years, 77.2% had limited disease, the median illness duration was 15.6 years, 15.7% were immunosuppressed, 32.1% had interstitial lung disease, and 6.4% had PAH. A total of 65.7% of consultations were by telehealth, of which 81.2% were by telephone. Compared with respondents in South Australia (n = 109), Victorian respondents (n = 203) experiencing prolonged lockdown, reported reduced access to their rheumatologist (49.3% vs 27.9%; P = 0.004), greater use of consultation by video (17.3% vs 2.1%; P = 0.008), greater health care disruption (49.0% vs 23.2%; P < 0.001), and worse mental health (P = 0.002). Respondents reported reduced access to PFT and TTE (31.7% and 22.5%, respectively). Annual visits, PFT, TTE, and new diagnoses of PAH were reduced in 2020 to 2022 compared with 2011 to 2019.Conclusion: The COVID‐19 pandemic–related disruption to health care for patients with SSc was associated with worse mental health and reduced screening and diagnosis of PAH, which may impact long‐term outcomes.